Impact of standardised osteopathic treatment of the frontalis muscles on anxiety disorders

Not Applicable

• Conditions: F40; F41; Phobic anxiety disorders; Other anxiety disorders

• Registration Number: DRKS00017663
• Lead Sponsor: Osteopathie Schule Deutschland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2018-03-22
• Study Start: 2019-07-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 7

Inclusion Criteria

For trial participation the patients had to fulfil the inclusion criteria by 1) been diagnosed with an anxiety disorder by a physician (ICD-10 conform) and 2) currently participating in psychotherapeutic sessions.

Exclusion Criteria

Within the exclusion criteria the patients weren´t allowed to be diagnosed with a disorder affecting facial expression 1) reductively like morbus parkinson, apraxia, autism, facial nerve paresis and spasm or 2) increasingly like huntington´s disease, west syndrome, schizophrenia and motor tics.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quantitative evaluation of the trial procedure, interventions, eligibility criteria, acquisition, harms and statistics took place after the follow-up.

Secondary Outcome Measures

Name	Time	Method
Qualitative evaluation of anxiety using the Beck Anxiety Inventory (BAI) and Numeric Rating Scale (NRS) took place before every treatment session and in the follow-up. The performance of a power analysis for planning of full-scale study took place after the follow-up.